|
CME ACCREDITATION
The Southern California Academy of Clinical Oncology is accredited by
the
Institute for Medical Quality/California Medical Association (IMQ/CMA) to
provide continuing medical education for physicians. The Southern California
Academy of Clinical Oncology takes responsibility for the content, quality and
scientific integrity of this CME activity.
The Southern California Academy of Clinical Oncology designates this educational
activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians
should only claim credit commensurate with the extent of their participation
in the activity. This credit may also be applied to the CMA Certification
in Continuing Medical Education.
 REGISTER NOW – CLICK HERE
TARGET
AUDIENCE
Hematologists, Medical, Surgical and Radiation Oncologists, Pathologists,
Oncology Nurses, Oncology Pharmacists, Fellows in Training and physicians in
active clinical practice who are interested and/or involved in the management
of patients with lymphomas and leukemias.
COURSE
OBJECTIVES
Needs assessments for this CME activity were derived from documented Southern
California epidemiological data, literature reviews and current clinical trials;
Needs presumed by the Program Committee and expressed needs from ACO members.
At the conclusion of this program, registrants should be able to discuss:
- Evaluate radiation therapy, autotransplantation and monoclonal antibody/chemotherapy
combinations in the treatment of large B cell lymphoma
- Discuss current status of radioimmunotherapeutic monoclonal antibody-based
therapy in the treatment of follicular lymphoma
- Compare various new agents, including dasatinib and AMN107 for imatinib-resistant
CML
- Determine the roles of alemtuzumab, rituximab and fludarabine for the
treatment of chronic lymphocytic leukemia
- Identify promising new agents in the treatment of MDS, including darbepoetin,
lenalidomide and decitabine
EDUCATION
GRANTS
This event is supported by Independent Educational Grants from:
Gold THE CALIFORNIA CANCER FOUNDATION
Silver GENENTECH BIOONCOLOGY
Others NOVARTIS ONCOLOGY
BERLEX
REGISTER NOW – CLICK HERE
ABOUT
ACO
The Academy was established on September 18, 1978 as a Non-Commercial
Professional Educational Society. It is a California Nonprofit Public Benefit
Corporation for Educational Purposes. IRS Tax Code Section 501(c)(3). Tax I.D.
95-3848332
THE ACO CME PROGRAM COMMITTEE
Alexandra Levine, MD - USC/Norris Cancer Center
Armando Giuliano, MD - John Wayne Cancer Institute
Derek Raghavan, MD, PhD, FACP, FRACP - The Cleveland Clinic
Frank Meyskens, MD - University of California, Irvine
Fred C. Kass, MD - The Santa Barbara Cancer Center
J Randolph Hecht, MD - UCLA
Jonathan S. Berek, MD - UCLA
Robert Morgan, MD - City of Hope
Ronald B. Natale, MD - Cedars Sinai Comprehensive Cancer Center
For more information:
Telephone: 213-977-1244
Fax: 213-977-1243
Technical Support: aco@commpartners.com
Website: www.scaco.org
|
